These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5785154)

  • 1. Possible functional differentiation between the stores from which adrenergic nerve stimulation, tyramine and amphetamine release noradrenaline.
    Obianwu HO
    Acta Physiol Scand; 1969; 75(1):92-101. PubMed ID: 5785154
    [No Abstract]   [Full Text] [Related]  

  • 2. Supersensitivity to tyramine during monoamine oxidase inhibition in man. Mechanism at the level of the adrenergic neuron.
    Pettinger WA; Oates JA
    Clin Pharmacol Ther; 1968; 9(3):341-4. PubMed ID: 5649986
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible functional differentiation between the stores from which adrenergic nerve stimulation, tyramine and amphetamine release noradrenaline.
    Obianwu HO
    Br J Pharmacol; 1968 Sep; 34(1):226P-227P. PubMed ID: 5676028
    [No Abstract]   [Full Text] [Related]  

  • 4. The degeneration contraction of a sympathetically innervated smooth muscle in the rat after reserpine, inhibition of monoamine oxidase or tyrosine hydroxylase.
    Lundberg D
    Acta Physiol Scand; 1970 Sep; 80(1):107-16. PubMed ID: 4394456
    [No Abstract]   [Full Text] [Related]  

  • 5. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of nerve stimulation on the uptake of noradrenaline into the adrenergic nerve terminals.
    Häggendal J; Malmfors T
    Acta Physiol Scand; 1969; 75(1):28-32. PubMed ID: 4306629
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of pargyline on overflow of transmitter and uptake of noradrenaline in the cat spleen.
    Blakeley AG; Powis G; Summers RJ
    Br J Pharmacol; 1973 Apr; 47(4):719-28. PubMed ID: 4353241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Influence of MAO-inhibitors on the intestinal absorption of biogenic amines.
    Huebers H; Huebers E; Huebers U; Rummel W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R36. PubMed ID: 4276566
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of chronic pretreatment with pargyline upon responses of the atrial pacemaker and of left atrial strips of guinea pigs to tyramine, mephentermine, d-amphetamine and adrenergic nerve stimulation.
    Antonaccio MJ; Smith CB
    J Pharmacol Exp Ther; 1969 Nov; 170(1):97-107. PubMed ID: 4900523
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions at adrenergic nerve endings.
    Salerni OL
    J Indiana State Med Assoc; 1972 Jun; 65(6):498-9. PubMed ID: 4643468
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions between monoamine oxidase inhibitors and sympathomimetic amines in the rat isolated vas deferens.
    Laporte J; Jané F; Valdecasas FG
    J Pharm Pharmacol; 1968 Feb; 20(2):148-9. PubMed ID: 4384539
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of nerve stimulation on catecholamines taken up in adrenergic nerves after reserpine pretreatment.
    Häggendal J; Malmfors T
    Acta Physiol Scand; 1969; 75(1):33-8. PubMed ID: 4306630
    [No Abstract]   [Full Text] [Related]  

  • 13. Histochemical and functional relationships of catecholamines in adrenergic nerve endings. II. Extravesicular norepinephrine.
    Van Orden LS; Bensch KG; Giarman NJ
    J Pharmacol Exp Ther; 1967 Mar; 155(3):428-39. PubMed ID: 6022617
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of tyramine, amphetamine and metaraminol on the metabolic disposition of 3 H-norepinephrine released from the adrenergic neuron.
    Leitz FH; Stefano FJ
    J Pharmacol Exp Ther; 1971 Sep; 178(3):464-73. PubMed ID: 4105925
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the effects of fenfluramine and amphetamine on uptake release and catabolism of norepinephrine in rat brain.
    Ziance RJ; Rutledge CO
    J Pharmacol Exp Ther; 1972 Jan; 180(1):118-26. PubMed ID: 5010409
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of norepinephrine synthesis in intact tissue dy drugs and during short-term adrenergic nerve stimulation.
    Weiner N; Cloutier G; Bjur R; Pfeffer RI
    Pharmacol Rev; 1972 Jun; 24(2):203-21. PubMed ID: 4405385
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of various MAO-B inhibitors on rabbit arterial strip response to tyramine.
    Abdorubo A; Knoll J
    Pol J Pharmacol Pharm; 1988; 40(6):673-83. PubMed ID: 3269534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
    Dénes B; Greeff K; Tawfik H
    Arzneimittelforschung; 1982; 32(3):201-7. PubMed ID: 6805481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid effects of monoamine oxidase inhibitors on synthesis and release of central monoamines.
    Glowinski J; Hamon M; Javoy F; Morot-Gaudry Y
    Adv Biochem Psychopharmacol; 1972; 5():423-39. PubMed ID: 4403372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.